Cyprus’ authorities announced on Sunday that they are investigating a new case of blood clot in a 40-year-old female, who is being treated at the Nicosia general hospital two weeks after getting the AstraZeneca vaccine.
The health ministry said that a report was filed at the Pharmacovigilance Department of the Pharmaceutical Services Saturday evening. The incident was detected during a pre-operation check up. The female was vaccinated with AstraZeneca two weeks before the incident and is in good condition, the health ministry added.
All data will be tabled to the European Medicines Agency for further investigation and to establish whether the blood clot incident is related to the vaccination.
The health ministry reminds all health professionals of the directions and recommendations given by EMA as regards the specific vaccine and what they need to look out in their patients.
According to the guidelines issued May 21, individuals who previously had blood clots with low blood platelets (thrombosis with thrombocytopenia syndrome, TTS) after Vaxzevria must not be given a second dose of Vaxzevria.
Individuals with low blood platelets within 3 weeks after vaccination with Vaxzevria should be actively investigated for signs of blood clots; similarly, individuals who present with blood clots within 3 weeks of vaccination should be evaluated for low blood platelets. Patients who have blood clots with low blood platelets after vaccination require specialist medical care. Hypersensitivity reactions presenting as hives or rapid swelling under the skin in areas such as the face, lips, mouth and throat are newly identified side effects of Vaxzevria. Vaxzevria is effective in preventing Covid-19.
Last week the ministry announced that a 39-year-old British woman is being treated at the Nicosia general hospital after a serious thrombotic episode. The woman was vaccinated on May 6 in Paphos and the European Medicines Agency has been informed. The Pharmaceutical Services were looking into any medication she was receiving, as well as her medical history and that of her family. The woman was vaccinated with AstraZeneca.